Lv4
530 积分 2025-05-29 加入
Bispecific antibodies: a mechanistic review of the pipeline
3小时前
已完结
Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo
6天前
已完结
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
15天前
已完结
Discovery and development of ADCs: obstacles and opportunities
1个月前
已完结
Expression levels of human P‐glycoprotein inIn Vitrocell lines: correlation between mRNA and protein levels for P‐glycoprotein expressed in cells
1个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
1个月前
已完结
Abstract A124: CBB-120: A TROP2-targeted dual-payload ADC combining Top1i and ATRi mechanisms demonstrates superior efficacy in preclinical models and improved safety in non-human primates
1个月前
已关闭
Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges
1个月前
已完结
State of the Art of Smo Antagonists for Cancer Therapy: Advances in the Target Receptor and New Ligand Structures
2个月前
已关闭
In vivo CAR-Ts captivate big pharma
2个月前
已完结
皖公网安备34019202002308
